INTERNSHIP DETAILS

Trainee (Regulatory science communication and engagement)

CompanyEMA
LocationAmsterdam
Work ModeOn Site
PostedApril 10, 2026
Internship Information
Core Responsibilities
The trainee will contribute to improving communication regarding the science underpinning the regulation of key biological medicines, focusing on vaccines and biosimilars. Specific tasks include supporting vaccine outreach group activities, preparing materials to address vaccine concerns, and reviewing/updating EMA information materials on biosimilar medicines.
Internship Type
full time
Company Size
1687
Visa Sponsorship
No
Language
English
Working Hours
40 hours
Apply Now →

You'll be redirected to
the company's application page

About The Company
The European Medicines Agency (EMA) is a decentralised body of the European Union with headquarters in Amsterdam. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use.
About the Role

Selection procedure reference: EMA/TR/11391 

Deadline for applications: 06 May 2026 23:59 CET 

 

The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam. It began operating in 1995. It is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.

 

This traineeship opportunity is now open for applications until 06 May 2026 23:59 CET, with an intake on 1 October 2026.

About the traineeship programme

The Agency is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students or Master's students (who posses a previous degree), who are interested in gaining experience and contribute to the Agency’s work for every patient in Europe. The purpose of a traineeship at the Agency is to perform tasks that are predominantly in the interest of the trainee’s training and principally serve to increase the trainee’s knowledge and to gain relevant experience.

Placement description

We are looking for a trainee in the Public and Stakeholders Engagement Department.

Specific objectives and projects

This traineeship is divided into two projects which aim to improve communication to the public of the science underpinning the regulation of key biological medicines. These are areas where public trust is needed for uptake and public health. The first part is to contribute to identifying and addressing concerns on vaccines, supporting EMA collaboration and engagement with stakeholders and addressing key issues through a multidisciplinary group across the Agency. The second project is to contribute to the review and update of EMA communication materials on biosimilar medicines. See: Biosimilar medicines: Overview

1) Contribute to activities of the vaccines outreach group (VOG), including work related to the following deliverables:
 
• Contributing to the preparation of VOG meetings and related outputs, including drafting meeting summaries.
• Contributing to activities of the Expert Group on Vaccine Confidence, including preparation of relevant materials.
• Preparing and reviewing communication materials (Vaccine Essentials) to address vaccine concerns and misinformation.
 
2) Contribute to the review and update of EMA information materials on biosimilar medicines, such as the guide for healthcare professionals: Biosimilars in the EU
 

Learning outcomes

How EMA communicates on regulatory science behind key biological medicines (biosimilars and vaccines) to ensure public understanding and trust.
How EMA identifies and addresses concerns on vaccines; How EMA collaborates and engages with stakeholders on key sensitive public health issues; How key issues are addressed via multidisciplinary group cross Agency.
 

Eligibility criteria

To be eligible for consideration for this placement, you are required to:

  1. enjoy full rights as a citizen of a European Union Member State or Iceland, Lichtenstein and Norway;
  2. possess a university degree in Pharmacy, medicine, or relevant public health related degree (minimum of three years or more) that must have been obtained between 6 May 2025 and 6 May 2026 or be a university student on an Erasmus + or a similar programme or a PhD student or a Master's student with a previous fully finished degree in the areas mentioned before.
  3. a thorough knowledge of English (at least level C1) and good knowledge of other official EU language (at least B2) of the Common European Framework for Languages

 

For criteria 1 and 2, you will be required to provide proof in the application form and at the interview stage. Failing to present these documents may result in the disqualification from the procedure.

Additional skills

Excellent communication skills (written and oral); analytical skills; knowledge and/or experience on vaccine / biosimilar communication and engaging with patients/healthcare professionals on vaccines/vaccination/biosimilar medicines.

Behavioural Competencies

You will demonstrate the following behavioural competencies:

  • Communication skills
  • Interpersonal skills
  • Working with others
  • Adaptability
  • Research and analytical skills
  • Learning and development

Conditions of traineeship

The traineeship is offered for 10 months (1 October 2026 – 31 July 2027) and takes place at the Agency’s premises in Amsterdam with possibility for teleworking up to 40% of working time from The Netherlands and occasional teleworking from outside The Netherlands. Traineeships are offered for either full-time or part-time (80% or 50%) if combined with university studies.

The Agency pays a monthly stipend of €2,049.77 for a full-time traineeship (reduced accordingly for 80% or 50%) and a travel contribution upon joining the Agency.

Each trainee will have a mentor at the Agency who will guide the trainee through the programme.

The conditions of employment are stated in the Executive Decision on rules governing the traineeship programme at the EMA available here.

Expected selection timelines

Deadline for applications 06 May 2026 23:59 CET 
Assessments (remote)From mid-June 2026 to mid-July 2026
Decision and offers By end of July 2026
Placement start 1 October 2026

 

______________________________________________________________________________________________________

Domenico Scarlattilaan 6 - 1083 HS Amsterdam - The Netherlands

Telephone +31 (0)88 781 6000 - Email recruitment@ema.europa.eu

 

© European Medicines Agency, 2024. Reproduction is authorised provided the source is acknowledged.

Key Skills
Communication SkillsAnalytical SkillsVaccine CommunicationBiosimilar CommunicationStakeholder EngagementRegulatory ScienceDrafting Meeting SummariesMaterial ReviewMisinformation AddressingInterpersonal SkillsAdaptabilityResearch SkillsLearning and Development
Categories
Science & ResearchHealthcareGovernment & Public SectorLegal
Benefits
Travel Contribution